Morrell Martha

Track

Insider profile

Morrell Martha's trades of Neuropace Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-03-04 2025-12-15
US Neuropace Inc (NPCE)
PlS Planned sale
93,761 +39.9%
394.95
US$3,253,586 		93,761 +39.9% 394.95 US$3,253,586
2025-12-15 2025-12-15
US Neuropace Inc (NPCE)
PrS Proposed sale
32,481
307.96
US$4,120,406 		32,481 307.96 US$4,120,406
2025-02-25 2025-02-21
US Neuropace Inc (NPCE)
PlS Planned sale
61,062 -9.4%
30.90
US$1,121,494 		61,062 -9.4% 30.90 US$1,121,494
2025-01-31 2025-01-30
US Neuropace Inc (NPCE)
PlS Planned sale
200 -0.2%
15.00
US$3,000 		200 -0.2% 15.00 US$3,000
2025-01-30 2025-01-30
US Neuropace Inc (NPCE)
PrS Proposed sale
78,534
14.69
US$1,153,664 		78,534 14.69 US$1,153,664
2025-01-31 2025-01-29
US Neuropace Inc (NPCE)
PlS Planned sale
100 -0.1%
15.00
US$1,500 		100 -0.1% 15.00 US$1,500
2025-01-29 2025-01-29
US Neuropace Inc (NPCE)
PrS Proposed sale
100
14.13
US$1,413 		100 14.13 US$1,413
2025-01-28 2025-01-24
US Neuropace Inc (NPCE)
PlS Planned sale
3,200 -3.5%
15.01
US$48,032 		3,200 -3.5% 15.01 US$48,032
2025-01-24 2025-01-24
US Neuropace Inc (NPCE)
PrS Proposed sale
3,200
14.02
US$44,864 		3,200 14.02 US$44,864
2024-02-06 2024-02-05
US Neuropace Inc (NPCE)
PlS Planned sale
3,446 -4.2%
15.17
US$52,278 		3,446 -4.2% 15.17 US$52,278
2024-02-06 2024-02-02
US Neuropace Inc (NPCE)
PlS Planned sale
14,143 -14.8%
15.07
US$213,122 		14,143 -14.8% 15.07 US$213,122
2024-02-01 2024-02-01
US Neuropace Inc (NPCE)
PlS Planned sale
663 -0.7%
15.04
US$9,971 		663 -0.7% 15.04 US$9,971
2024-02-01 2024-01-31
US Neuropace Inc (NPCE)
PlS Planned sale
1,923 -2.0%
15.08
US$28,990 		1,923 -2.0% 15.08 US$28,990
2024-02-01 2024-01-30
US Neuropace Inc (NPCE)
PlS Planned sale
11,262 -10.3%
15.10
US$170,004 		11,262 -10.3% 15.10 US$170,004
2024-01-26 2024-01-25
US Neuropace Inc (NPCE)
PlS Planned sale
1 -0.0%
15.00
US$15 		1 -0.0% 15.00 US$15
2024-01-26 2024-01-24
US Neuropace Inc (NPCE)
PlS Planned sale
827 -0.8%
15.03
US$12,426 		827 -0.8% 15.03 US$12,426
2023-12-28 2023-12-27
US Neuropace Inc (NPCE)
PlS Planned sale
13,300 -10.8%
10.12
US$134,648 		13,300 -10.8% 10.12 US$134,648
2023-12-28 2023-12-26
US Neuropace Inc (NPCE)
PlS Planned sale
102 -0.1%
10.00
US$1,020 		102 -0.1% 10.00 US$1,020
2023-12-22 2023-12-20
US Neuropace Inc (NPCE)
PlS Planned sale
2,730 -2.2%
10.14
US$27,695 		2,730 -2.2% 10.14 US$27,695
2023-12-20 2023-12-20
US Neuropace Inc (NPCE)
PrS Proposed sale
48,397
9.99
US$483,486 		48,397 9.99 US$483,486
2023-12-07 2023-12-06
US Neuropace Inc (NPCE)
PlS Planned sale
11,005 -8.0%
8.16
US$89,773 		11,005 -8.0% 8.16 US$89,773
2023-12-06 2023-12-06
US Neuropace Inc (NPCE)
PrS Proposed sale
11,005
8.16
US$89,773 		11,005 8.16 US$89,773